Search

Displaying results 7751 - 7760 of 10000 in total
  1. Drug

    BEA-17

    go.drugbank.com/drugs/DB18574
    Experimental

    BEA-17 is a small molecule targeted degrader of the epigenetic enzyme LSD1 and its co-factor CoREST.[L48330] It is under investigation for the treatment of glioblastoma.

  2. Drug

    LX6171

    go.drugbank.com/drugs/DB05180
    Investigational

    LX6171 is an oral drug candidate that was generated by Lexicon medicinal chemists and is being developed to treat disorders characterized by cognitive impairment, such as Alzheimer's disease, schizophrenia

  3. Drug

    Bapineuzumab

    go.drugbank.com/drugs/DB11715
    Investigational

    Bapineuzumab has been investigated for the treatment of Alzheimer's Disease.

  4. Drug

    Pefcalcitol

    go.drugbank.com/drugs/DB11786
    Investigational

    Pefcalcitol has been investigated for the basic science of Psoriasis.

  5. Drug

    Bi104

    go.drugbank.com/drugs/DB18743
    Experimental

    Bi104 is being investigated for the treatment of Angelman syndrome.

  6. Drug

    Doxifluridine

    go.drugbank.com/drugs/DB12947
    Investigational

    Doxifluridine has been investigated for the treatment of Stomach Cancer.

  7. Drug

    Saroglitazar

    go.drugbank.com/drugs/DB13115
    Investigational

    Saroglitazar has been investigated for the treatment of Fatty Liver.

  8. Drug

    Aminomethylbenzoic acid

    go.drugbank.com/drugs/DB13244
    Experimental

    Aminomethylbenzoic acid may be useful as an antifibrinolytic agent [A174994].

  9. Drug

    Epelsiban

    go.drugbank.com/drugs/DB11934
    Investigational

    Epelsiban has been investigated for the treatment of Premature Ejaculation.

  10. Drug

    Visilizumab

    go.drugbank.com/drugs/DB12053
    Investigational

    Visilizumab has been investigated for the treatment of Ulcerative Colitis.